![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 38, 35232-35239, September 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the GSH synthesis occurs via two enzymatic steps
catalyzed by glutamate-cysteine ligase (GCL, made up of two subunits)
and GSH synthetase (GS). Recently, we described coordinate induction of GCL subunits and GS. To study GS transcriptional regulation, we have
cloned and characterized a 2.2-kb 5'-flanking region of the rat GS
(GenBankTM accession number AF333982). One
transcriptional start site is located at 51 nucleotides upstream of the
translational start site. The rat GS promoter drove efficiently
luciferase expression in H4IIE cells. Sequential deletion analysis
revealed DNA regions that are involved in positive and negative
regulation. One repressor identified was NF1.
tert-Butylhydroquinone (TBH) exerted a dose- and
time-dependent increase in the mRNA level and promoter
activity of both GCL subunits and GS. TBH increased protein binding to several regions of the GS promoter, c-jun expression, and
activator protein 1 (AP-1) binding activity to several of the putative
AP-1-binding sites of the GS promoter. Blocking AP-1 binding with
dominant-negative c-jun led to decreased basal expression
and significantly blocked the TBH-induced increase in promoter activity
and mRNA level of all three genes. In conclusion, AP-1 is required
for basal expression of GCL and GS; while NF1 serves as a repressor of
GS, increased AP-1 transactivation is the predominant mechanism for
coordinate induction of GCL and GS expression by TBH.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF333982.
Role of AP-1 in the Coordinate Induction of Rat
Glutamate-cysteine Ligase and Glutathione Synthetase by
tert-Butylhydroquinone*
,
,
§,
,
,
,
,
Division of Gastroenterology and Liver
Diseases, University of Southern California Liver Disease Research
Center, USC-UCLA Research Center for Alcoholic Liver and Pancreatic
Diseases, Keck School of Medicine, University of Southern California,
Los Angeles, California 90033 and the ¶ Department of
Medicine, University of North Carolina,
Chapel Hill, North Carolina 27599
*
This work was supported in part by National Institutes of
Health Grants DK-45334 (to S. C. L.) and AA10459 (to R. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Division of
Gastrointestinal and Liver Diseases, HMR Bldg., 415, Dept. of Medicine, University of Southern California School of Medicine, 2011 Zonal Ave.,
Los Angeles, CA 90033. Tel.: 323-442-2441; Fax: 323-442-3234; E-mail:
shellylu@hsc.usc.edu.
This article has been cited by other articles:
![]() |
M.-F. Yueh and R. H. Tukey Nrf2-Keap1 Signaling Pathway Regulates Human UGT1A1 Expression in Vitro and in Transgenic UGT1 Mice J. Biol. Chem., March 23, 2007; 282(12): 8749 - 8758. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, N. Magilnick, C. Lee, D. Kalmaz, X. Ou, J. Y. Chan, and S. C. Lu Nrf1 and Nrf2 Regulate Rat Glutamate-Cysteine Ligase Catalytic Subunit Transcription Indirectly via NF-{kappa}B and AP-1 Mol. Cell. Biol., July 15, 2005; 25(14): 5933 - 5946. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, M. R. Sadda, V. Yu, Y. Zeng, T. D. Lee, X. Ou, L. Chen, and S. C. Lu Induction of Human Methionine Adenosyltransferase 2A Expression by Tumor Necrosis Factor {alpha}: ROLE OF NF-{kappa}B AND AP-1 J. Biol. Chem., December 19, 2003; 278(51): 50887 - 50896. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |